{"id":2830,"date":"2021-11-30T10:07:28","date_gmt":"2021-11-30T09:07:28","guid":{"rendered":"https:\/\/wp.idlbiotech.com\/?page_id=2830"},"modified":"2025-05-27T09:01:22","modified_gmt":"2025-05-27T07:01:22","slug":"annual-general-meeting","status":"publish","type":"page","link":"https:\/\/idldiagnostics.com\/se\/investors\/corporate-governance\/annual-general-meeting\/","title":{"rendered":"Ordinarie bolagsst\u00e4mma"},"content":{"rendered":"

[et_pb_section fb_built=”1″ _builder_version=”4.16″ _module_preset=”88f366a5-bf49-48d9-a338-ab22706b73e7″ global_colors_info=”{}”][et_pb_row _builder_version=”4.18.0″ _module_preset=”default” custom_padding=”0px||0px|||” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” custom_padding=”||||false|false” custom_padding_tablet=”10px||||false|false” custom_padding_phone=”0px||||false|false” custom_padding_last_edited=”on|phone” global_colors_info=”{}”][dipi_breadcrumbs _builder_version=”4.27.4″ _module_preset=”default” max_width=”800px” global_module=”5132″ global_colors_info=”{}”][\/dipi_breadcrumbs][et_pb_divider color=”#EEEEEE” _builder_version=”4.16″ _module_preset=”default” max_width=”800px” min_height=”1px” height=”20px” custom_margin=”||3px|||” global_colors_info=”{}”][\/et_pb_divider][et_pb_text _builder_version=”4.18.0″ _module_preset=”8738c908-7375-4c6c-99a7-9f91f8a3c099″ header_font_size=”56px” max_width=”800px” custom_margin=”||17px|||” global_colors_info=”{}”]<\/p>\n

ANNUAL GENERAL MEETING<\/h6>\n

Annual General Meeting.<\/h1>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.18.0″ _module_preset=”e9afc0e7-c9bf-4a12-be49-63ddba231101″ global_colors_info=”{}”][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.18.0″ _module_preset=”default” width=”100%” max_width=”100%” global_colors_info=”{}”]<\/p>\n

Right to attend the annual general meeting<\/h3>\n

Shareholders\u2019 rights to decide on the company\u2019s affairs are exercised through the highest decision-making body, the Annual General Meeting (Annual General Meeting and Extra General Meeting).<\/p>\n

Shareholders who wish to participate in the Annual General Meeting of the company should be included in the register of shareholders held by Euroclear Sweden five weekdays before the meeting, and notify the company of their participation in the Annual General Meeting by the date stated in the notice convening the meeting. Shareholders may attend general meetings by person or by proxy and may also be assisted by no more than two persons. How shareholders register for the Annual General Meeting will be further specified in the notice of the meeting. Shareholders are entitled to vote for all the shares held by the shareholder. Notice of shareholders\u2019 meetings shall be published in the Swedish Official Gazette and on the company\u2019s website, within such time as set forth in the Swedish Companies Act. It shall be announced in Dagens Industri that a notice has been issued.<\/p>\n

Shareholders wishing to have a case dealt with at the Annual General Meeting must send a written request to this effect to the Board of Directors of the company. The request should normally be submitted to the Board no later than 6 weeks before the Annual General Meeting.<\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_accordion toggle_icon=”3||divi||400″ _builder_version=”4.27.4″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][et_pb_accordion_item title=”#1 – R\u00f6r ej” open=”on” _builder_version=”4.17.4″ _module_preset=”default” custom_css_main_element=”Display:none;” global_colors_info=”{}”][\/et_pb_accordion_item][et_pb_accordion_item title=”Annual general meeting 2025″ _builder_version=”4.27.4″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” open=”off” sticky_enabled=”0″]<\/p>\n

All documents are in Swedish.<\/h5>\n

Notice of Annual General Meeting 2025<\/a><\/p>\n

Appendix 1 The Nomination Committee’s reasoned statement and information on board members<\/a><\/p>\n

Authorization form<\/a><\/p>\n

Proposal for issue authorization in 2025<\/a><\/p>\n

Proposal for change in Articles of Association<\/a><\/p>\n

Link to online registration<\/a><\/p>\n

Link to digital mail vote<\/a><\/p>\n

The nomination committee’s proposal for the 2025 annual general meeting<\/a><\/p>\n

Minutes from the Annual General Meeting 2025<\/a><\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”Annual general meeting 2024″ _builder_version=”4.25.2″ _module_preset=”default” global_colors_info=”{}” open=”off”]<\/p>\n

All documents are in Swedish.<\/h5>\n

Notice of Annual General Meeting 2024<\/a><\/p>\n

Appendix 1 The Nomination Committee’s reasoned statement and information on board members<\/a><\/p>\n

Authorization form<\/a><\/p>\n

Proposal for issue authorization in 2024<\/a><\/p>\n

Link to online registration<\/a><\/p>\n

Link to digital mail vote<\/a><\/p>\n

The nomination committee’s proposal for the 2023 annual general meeting<\/a><\/p>\n

<\/a>Minutes from the Annual General Meeting 2024<\/a><\/p>\n

 <\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”Annual general meeting 2023″ _builder_version=”4.23.1″ _module_preset=”default” global_colors_info=”{}” open=”off”]<\/p>\n

All documents are in Swedish.<\/h5>\n

Notice of Annual General Meeting 2023<\/a><\/p>\n

Appendix 1 The Nomination Committee’s reasoned statement and information on board members<\/a><\/p>\n

Authorization form<\/a><\/p>\n

Proposal for a directed issue of warrants<\/a><\/p>\n

Warrant terms<\/a><\/p>\n

Issuance authorization<\/a><\/p>\n

Link to online registration<\/a><\/p>\n

Link to digital mail vote<\/a><\/p>\n

The nomination committee’s proposal for the 2023 annual general meeting<\/a><\/p>\n

Minutes from the Annual General Meeting 2023<\/a><\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”Annual general meeting 2022″ _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}” open=”off”]<\/p>\n

All documents are in Swedish.<\/h5>\n

Notice of Annual General Meeting 2022<\/a><\/p>\n

Issue authorization<\/a><\/p>\n

The Nomination Committee\u2019s proposal for the 2022 Annual General Meeting<\/a><\/p>\n

Proposal for new articles of association<\/a><\/p>\n

Minutes from the Annual General Meeting 2022 \u2013 With attachments<\/a><\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”Annual general meeting 2021″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}” open=”off”]<\/p>\n

All documents are in Swedish.<\/h5>\n

Notice of annual general meeting of AroCell AB<\/a><\/p>\n

The Board\u2019s proposal \u2013 Authorization<\/a><\/p>\n

Nomination Committee\u2019s proposal to the Annual General Meeting 2021<\/a><\/p>\n

Proposal for new articles of association<\/a><\/p>\n

Minutes from the Annual General Meeting 2021<\/a><\/p>\n

\u2013Attachment 1<\/a><\/p>\n

\u2013Attachment 2<\/a><\/p>\n

\u2013Attachment 3<\/a><\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”Annual general meeting 2020″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}” open=”off”]<\/p>\n

All documents are in Swedish.<\/h5>\n

Notice of annual general meeting of AroCell AB<\/a><\/p>\n

The Board\u2019s proposal \u2013 Authorization<\/a><\/p>\n

Nomination Committee\u2019s proposal to the Annual General Meeting 2020<\/a><\/p>\n

Information regarding the Annual General Meeting 2020<\/a><\/p>\n

Minutes from the Annual General Meeting 2020<\/a><\/p>\n

Presentation AroCell AB (publ) Annual General Meeting 2020<\/a><\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”Annual general meeting 2019″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}” open=”off”]<\/p>\n

All documents are in Swedish.<\/h5>\n

Notice of annual general meeting of AroCell AB<\/a>
\u2013 Comment on the Nomination Committee\u2019s proposal for Board members (Swedish)<\/a><\/p>\n

Nomination Committee\u2019s proposal to the Annual General Meeting 2019<\/a><\/p>\n

The Board\u2019s proposal \u2013 Change<\/a><\/p>\n

The Board\u2019s proposal \u2013 Authorization<\/a><\/p>\n

The Board\u2019s proposal \u2013 Directed issue NR1<\/a>
\u2013 Agreement NR1<\/a>
\u2013 Appendix 1 NR1<\/a>
\u2013 Appendix 2 NR1<\/a><\/p>\n

Jon Eiken\u2019s proposal \u2013 Directed issue NR2<\/a>
\u2013 Agreement NR2<\/a>
\u2013 Appendix 1 NR2<\/a>
\u2013 Appendix 2 NR2<\/a><\/p>\n

Presentation AroCell AB (publ) Annual General Meeting 2019<\/a><\/p>\n

Minutes from the Annual General Meeting<\/a><\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”Annual general meeting 2018″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}” open=”off”]<\/p>\n

Kallelse till \u00e5rsstamma 2018 AroCell AB (Publ)<\/a><\/p>\n

Presentation AroCells styrelse 2018<\/p>\n

Instruktion och arbetsordning f\u00f6r valberedningen i AroCell<\/p>\n

Presentation \u00e5rsst\u00e4mma 2018 AroCell AB (publ)<\/p>\n

2018-06-15 kommunik\u00e9 fr\u00e5n \u00e5rsst\u00e4mma<\/p>\n

Protokoll fr\u00e5n \u00e5rsst\u00e4mma<\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”Annual general meeting 2017″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}” open=”off”]<\/p>\n

Presentation \u00e5rsst\u00e4mman 2017 AroCell AB (publ)<\/a><\/p>\n

Beslut vid \u00e5rsst\u00e4mman i AroCell AB 2017 (Publ)<\/a><\/p>\n

Kallelse till \u00e5rsst\u00e4mma 2017 AroCell AB (Publ)<\/a><\/p>\n

Presentation AroCell AB styrelse 2017<\/a><\/p>\n

Styrelsens f\u00f6rslag till Personaloptionsprogram 2017-2020<\/a><\/p>\n

Optionsvillkor AroCell AB<\/a><\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”Annual general meeting 2016″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}” open=”off”]<\/p>\n

Notice of Annual General Meeting 2016 (SWE)<\/a><\/p>\n

Proposal by the Board of Directors on authorization (SWE)<\/a><\/p>\n

Instructions for the Nomination Committee (SWE)<\/a><\/p>\n

AroCell-PR-160519-Report-AGM-Eng<\/a><\/p>\n

AroCell-PM-160519-Kommunik\u00e9\u200b (SWE)<\/a><\/p>\n

[\/et_pb_accordion_item][et_pb_accordion_item title=”Annual general meeting 2015″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}” open=”off”]<\/p>\n

The annual general meeting of AroCell AB (publ) was held on 3 June 2015. The following provides a summary of the resolutions passed. All resolutions were passed with the required majority.<\/h5>\n

4,627,983 (19.7 %) of the total of 23,460,960 shares were represented at the meeting.<\/p>\n

The meeting passed a resolution to adopt the presented income statement and balance sheet. The meeting also passed a resolution to allocate the company\u2019s loss in accordance with the Board of Directors\u2019 proposal in the annual accounts. It was further resolved that no dividend would be paid for the 2014 financial year.<\/p>\n

The general meeting passed a resolution regarding discharge from liability for members of the Board of Directors and the CEO.<\/p>\n

The general meeting passed a resolution that the Board of Directors shall comprise five ordinary members and to appoint one auditor without a deputy.<\/p>\n

The meeting passed a resolution that the board fee shall be SEK 150,000 for the chairman and SEK 50,000 for other board members. It was further resolved that the auditor\u2019s fee shall be based on an approved invoice.<\/p>\n

The general meeting passed a resolution to re-elect Erik Walld\u00e9n, H\u00e5kan Englund, Staffan Eriksson and Jan Mellberg, and to elect Carl Blomqvist as a new member of the Board. Erik Walld\u00e9n was appointed chairman of the Board of Directors.<\/p>\n

The meeting re-elected Bj\u00f6rn Ohlsson of Ernst & Young as auditor.<\/p>\n

All the above elections relate to the period until the next annual general meeting.<\/p>\n

The meeting passed a resolution to appoint a nominating committee ahead of the 2016 annual general meeting and adopted Instructions and rules of procedure for the nominating committee.<\/p>\n

The meeting passed a resolution to authorise the Board of Directors to decide to implement a new issue of shares or other financial instruments in accordance with the proposal in the notice convening the meeting. The resolution was passed unanimously.<\/p>\n

For further information:
Jan St\u00e5lemark, CEO
AroCell AB (publ)
Tel: +46 (0)18-50 30 20
E-mail: jan.stalemark@arocell.com<\/p>\n

AroCell AB (publ) in brief<\/strong>
AroCell AB (publ) is a Swedish company located in Uppsala. AroCell\u2019s technology is based on an innovative method for measuring how quickly cells divide in the body, which can provide a measure of how aggressive a cancer tumour is. This is done using a simple blood sample and a laboratory test. The test, TK 210 ELISA, provides clinically valuable information for assessing prognosis, monitoring the effectiveness of cancer treatment, and treatment optimisation. The test is also ideal for following up and checking for possible recurrence. AroCell is listed on the AktieTorget marketplace in Sweden and has around 1,650 shareholders.<\/p>\n

[\/et_pb_accordion_item][\/et_pb_accordion][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.16″ _module_preset=”default” global_module=”3466″ saved_tabs=”all” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_menu menu_id=”29″ disabled_on=”on|on|off” _builder_version=”4.18.0″ _module_preset=”default” background_color=”#F8F8F8″ global_colors_info=”{}”][\/et_pb_menu][et_pb_sidebar area=”et_pb_widget_area_2″ disabled_on=”off|off|on” _builder_version=”4.16″ _module_preset=”2efbbc8f-7ecb-4fe3-9956-d83a8a0e7a74″ background_color=”#F8F8F8″ global_colors_info=”{}”][\/et_pb_sidebar][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”on|tablet” _builder_version=”4.9.4″ _module_preset=”default” custom_margin_tablet=”||||false|false” custom_margin_phone=”” custom_margin_last_edited=”on|tablet” custom_padding_tablet=”||0px||false|false” custom_padding_phone=”” global_module=”2177″ saved_tabs=”all” global_colors_info=”{}”][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_text_color=”#21242A” global_colors_info=”{}”]<\/p>\n

About us<\/h6>\n

We provide knowledge to decision.<\/h3>\n

AroCell is a Swedish diagnostics company with the vision to improve the monitoring of oncological and bacterial diseases. We have a broad product portfolio of IVD tests that deliver high-value clinical information for the detection of diseases.<\/p>\n

[\/et_pb_text][et_pb_button button_url=”https:\/\/idldiagnostics.com\/about-arocell\/” button_text=”Read more about us” _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_button][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/MG_7941-800.jpg” title_text=”MG_7941-600″ src_tablet=”” src_phone=”https:\/\/idldiagnostics.com\/wp-content\/uploads\/2023\/08\/MG_7941-600.jpg” src_last_edited=”on|phone” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”on|tablet” _builder_version=”4.16″ _module_preset=”default” custom_padding_tablet=”||0px||false|false” custom_padding_phone=”” global_module=”2428″ saved_tabs=”all” global_colors_info=”{}”][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Bacteriology<\/h6>\n

An effective typhoid test<\/h3>\n

Typhoid fever is water and food-borne infectious disease caused by the bacterium, Salmonella<\/em> enterica. IDL Biotechs product TUBEX\u00ae TF, is a rapid and sensitive in vitro diagnostic test for the detection of acute typhoid fever.<\/p>\n

[\/et_pb_text][et_pb_button button_url=”https:\/\/idldiagnostics.com\/products\/bacteriology\/” button_text=”Read more about bacteriology” _builder_version=”4.18.0″ _module_preset=”5e8c1032-9074-49bb-92a6-99c20ecc3d02″ global_colors_info=”{}”][\/et_pb_button][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/girl-water.jpeg” title_text=”Water is Life for African Children, Little Gorgeous Black Girl Drinking from Tap” _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”on|tablet” _builder_version=”4.16″ _module_preset=”default” custom_padding_tablet=”||0px||false|false” custom_padding_phone=”” global_module=”2365″ saved_tabs=”all” global_colors_info=”{}”][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.22.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Oncology<\/h6>\n

Diagnostics for oncology<\/h3>\n

Cancer is one of the leading causes of death worldwide, despite advancing knowledge. To improve cancer patient management, there is a clear need for efficient diagnostics tools to capture this critical clinical data.<\/span><\/p>\n

[\/et_pb_text][et_pb_button button_url=”https:\/\/idldiagnostics.com\/products\/oncology\/” button_text=”Read more about oncology” _builder_version=”4.22.1″ _module_preset=”5e8c1032-9074-49bb-92a6-99c20ecc3d02″ global_colors_info=”{}”][\/et_pb_button][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/girl-sunset.jpeg” title_text=”Happy smiling running beagle dog portrait with tongue out and owner female jogging by the mounting meadow grass path. Walking in nature with pets, happy healthy active people lifestyle concept image.” _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\t
\n